SFC Global Supply Chain, Inc.Download PDFPatent Trials and Appeals BoardApr 28, 20212020006435 (P.T.A.B. Apr. 28, 2021) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 15/352,183 11/15/2016 Rongxuan Cai 02661.0685USU1 7854 23552 7590 04/28/2021 MERCHANT & GOULD P.C. P.O. BOX 2903 MINNEAPOLIS, MN 55402-0903 EXAMINER BADR, HAMID R ART UNIT PAPER NUMBER 1791 NOTIFICATION DATE DELIVERY MODE 04/28/2021 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): USPTO23552@merchantgould.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE ____________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ____________ Ex parte RONGXUAN CAI and STACEY FOWLER MEITTUNEN Appeal 2020-006435 Application 15/352,183 Technology Center 1700 ____________ Before LINDA M. GAUDETTE, DONNA M. PRAISS, and MERRELL C. CASHION, JR., Administrative Patent Judges. PRAISS, Administrative Patent Judge. DECISION ON APPEAL1 Pursuant to 35 U.S.C. § 134(a), Appellant2 appeals from the Examiner’s decision to reject claims 1–41. An oral hearing was held on April 22, 2021.3 We have jurisdiction under 35 U.S.C. § 6(b). We REVERSE. 1 In this Decision, we refer to the Specification filed Nov. 15, 2016 (“Spec.”), the Final Office Action dated Nov. 19, 2019 (“Final Act.”), the Appeal Brief filed Mar. 17, 2020 (“Appeal Br.”), and the Examiner’s Answer dated May 15, 2020 (“Ans.”). 2 We use the word “Appellant” to refer to “applicant” as defined in 37 C.F.R. § 1.42. Appellant identifies SFC Global Supply Chain, Inc., as the real party in interest. Appeal Br. 2. 3 A transcript of the hearing will be placed in the record when available. Appeal 2020-006435 Application 15/352,183 2 STATEMENT OF THE CASE The invention relates to frozen dough products and methods of making frozen dough products that have been proofed and include a spent yeast portion and a preserved yeast portion. Spec. 1:6–8. According to the Specification, “spent yeast” refers to yeast that has gone through an active metabolic phase in proofing and is no longer viable. Id. at 4:22–23. The Specification defines “preserved yeast” as “not used” during proofing, but, instead, “reserved during proofing.” Id. at 11:27–12:1. The Specification describes “proofing” as a final fermentation step before baking in the preparation of yeast-leavened baked goods. Id. at 5:15–16. The Specification describes both “coated yeast” and “encapsulated yeast” as yeast that has been coated with a fat, however, “[e]ncapsulated yeast includes granules of yeast cells” and “is typically available as a flowable granulated material, whereas coated yeast may be present . . . without the presence of separate granules.” Id. at 9:7–8, 12:27–13:1. Claims 1 and 13, reproduced below, are illustrative. 1. A proofed frozen dough comprising: (a) a dough mixture of flour, water, and optionally additives, the dough mixture defining a dough matrix; (b) gas bubbles dispersed throughout the dough matrix; (c) a spent yeast component; and (d) a preserved yeast component comprising a fat-coated yeast, a non-hydrated yeast or a combination thereof. 13. A method for making a frozen dough product, the method comprising: (a) mixing dough ingredients to produce a dough composition, the dough ingredients comprising: i. water; Appeal 2020-006435 Application 15/352,183 3 ii. flour; iii. a first yeast; and iv. a second yeast; (b) proofing the dough, wherein during proofing the first yeast is spent and the second yeast is preserved; (c) compressing the dough during or after proofing, and before freezing; and (d) freezing the dough after proofing wherein compressing the dough results in an increased final product volume after the frozen dough product is baked compared to an identical dough product made without a compressing step. Appeal Br. 22, 23 (Claims Appendix) (disputed elements italicized). ANALYSIS We review the appealed rejections for error based upon the issues Appellant identifies, and in light of the arguments and evidence produced thereon. Ex parte Frye, 94 USPQ2d 1072, 1075 (BPAI 2010) (precedential) cited with approval in In re Jung, 637 F.3d 1356, 1365 (Fed. Cir. 2011) (“[I]t has long been the Board’s practice to require an applicant to identify the alleged error in the examiner’s rejections.”). After considering the argued claims and each of Appellant’s arguments, we are persuaded of reversible error in the appealed rejections. The Examiner’s rejections rely on the following references: Name Reference Date Lee US 6,835,397 B2 Dec. 28, 2004 Goedeken US 2003/0104100 A1 June 5, 2003 Bonjean US 2011/033574 A1 Feb. 10, 2011 Appeal 2020-006435 Application 15/352,183 4 The Examiner maintains the following rejections: Claims Rejected 35 U.S.C. § Reference/Basis 1–12 112(b) Indefiniteness 1–12 103 Goedeken, Lee 13–41 103 Goedeken, Lee, Bonjean Indefiniteness Rejection The Examiner rejects claims 1–12 under 35 U.S.C. § 112(b) as being indefinite because the Examiner determines both the “spent yeast” and the “non-hydrated yeast” can be dried yeast, therefore it is unclear how dried yeast can be both “spent” and at the same time “preserved.” Final Act. 2. Because claims 2–12 depend from claim 1, we need only consider claim 1 to resolve this issue. According to Appellant, the claim language and the Specification are not confusing or unclear as to which yeasts are suitable for generating the spent and preserved yeast. Appeal Br. 7. Appellant directs us to Specification page 12 which describes that the one yeast becomes spent during a first proofing step and the other yeast remains preserved or unspent following the first proofing step. Id. at 8 (citing Spec. 12:10–15). Appellant describes how both yeasts can be dried, but the first yeast gets activated by being mixed with water when the dough is formed while the second yeast becomes active after the proofing step is complete by hydrating slowly within the dough. Id. We are persuaded by Appellant’s arguments that the claim language is definite as to what constitutes a preserved yeast. As Appellant notes, the claim is directed to the dough at a particular snapshot in time when it is Appeal 2020-006435 Application 15/352,183 5 proofed and frozen, not when it is being mixed or after freezing and before baking. Appeal Br. 7. The Examiner states that the preserved yeast cannot be “non-hydrated” as claimed because it would be slowly hydrated and active by the completion of the proofing stage. Ans. 9. Slowly hydrating the dough after proofing is complete, however, does not mean that the preserved yeast is hydrated at the point when the first proofing is complete. Appellant’s assertion (Appeal Br. 8) that the “second yeast is not activated with water [when the dough is being formed] but rather gets mixed in separately so that it hydrates slowly within the dough and becomes active after the proofing step is complete” is supported by the Specification which provides that the second yeast is “unavailable during fermentation or proofing.” Spec. 17: 1– 2. Moreover, the Examiner appears to be arguing the breadth of the claim. While the disputed language may render the scope of the claims broad, claims are not indefinite on the basis of their breadth alone. See In re Gardner, 427 F.2d 786, 788 (CCPA 1970) (“Breadth is not indefiniteness.”). The preponderance of the evidence in this appeal record therefore supports Appellant’s position that the terms “spent yeast” and “preserved yeast,” when read in light of the specification, reasonably apprise those skilled in the art both of the utilization and scope of the invention. In re Packard, 751 F.3d 1307, 1313 (Fed. Cir. 2014); Hybritech Inc. v. Monoclonal Antibodies, Inc., 802 F.2d 1367, 1385 (Fed. Cir. 1986). Accordingly, we reverse the Examiner’s rejection of claim 1, as well as claims 2–12, under 35 U.S.C. § 112(b) for the above reasons and those provided by Appellant. Appeal 2020-006435 Application 15/352,183 6 Obviousness Rejection of Claims 1–12 The Examiner rejects claims 1–12 under 35 U.S.C. § 103 as unpatentable over the combination of Goedeken and Lee. Final Act. 3. The Examiner finds Goedeken discloses yeast leavened proofed frozen doughs, but is silent regarding the inclusion of encapsulated (protected or preserved) yeast in the frozen dough product. Id. at 3–4. The Examiner finds Lee teaches frozen dough comprising encapsulated yeast has improved shelf stability and the encapsulation of the yeast protects the yeast during shelf storage. Id. at 4–5. The Examiner finds that Lee’s monoglyceride coating functions as a barrier to moisture and a person having ordinary skill in the art would not have expected the encapsulated yeast to start generating carbon dioxide shortly after the dough is formed in water. Id. at 5 (citing Lee, Example 1). The Examiner determines it would have been obvious to one skilled in the art to modify Goedeken product/process by incorporating encapsulated yeast into the dough before freezing as motivated by Lee to extend the shelf life of the frozen dough and “enable the dough to compensate for the lost carbon dioxide during frozen storage before baking.” Id. at 6; Ans. 7. Appellant argues that Goedeken and Lee are alternative strategies for creating frozen dough, with Goedeken’s yeast dough being proofed before freezing (i.e., the yeast is spent) and Lee’s frozen product being formed before proofing (i.e., the yeast is preserved until proofing). Appeal Br. 10. According to Appellant, both yeasts in Goedeken and Lee become spent in the proofing process and there is no yeast left to remain preserved. Id. at 11. Appellant asserts the Examiner’s selection of Lee’s encapsulated yeast as surviving Goedeken’s proofing process is contrary to the prior art teachings Appeal 2020-006435 Application 15/352,183 7 and is exclusively based on hindsight reconstruction using Appellant’s disclosure as a guide. Id. Appellant contends that a person with skill in the art would expect Lee’s encapsulated yeast to start generating carbon dioxide shortly after the dough is formed in water because Lee’s encapsulated yeast activate rather than remain preserved when subject to proofing. Id. at 10 (citing Lee, Example 3). We find Appellant’s above arguments persuasive of reversible error. While Appellant’s recited “fat-coated yeast” encompasses Lee’s encapsulated yeast coated with monoglycerides, which is fatty material, the Examiner’s finding that Lee’s “protected yeast is capable of surviving the proofing process” is not supported by the record. Ans. 11; Lee 2:8–13. Lee teaches that the monoglyceride coating functions as a barrier to oxygen and moisture, thus extending the storage time of yeast. Lee 11:38–41 (Example 1). Lee also teaches “upon exposure of the encapsulated yeast composite with water, the yeast is released.” Lee 12:11–12. Therefore, the Examiner’s selection of Lee’s encapsulated yeast to survive proofing and “[t]o compensate for the lost carbon dioxide during storage” of Goedeken’s frozen dough by activating after thawing the dough appears to be the result of impermissible hindsight that Graham v. John Deere Co., 383 U.S. 1, 36 (1966), warns against. The preponderance of the evidence in this appeal record therefore does not support the Examiner’s rejection of claim 1. Accordingly, we reverse the Examiner’s rejection of claim 1 under 35 U.S.C. § 103 for the above reasons. We also reverse the rejection of claims 2–12, which each depend from claim 1, based on the same error in the Examiner’s combination of Goedeken and Lee. Appeal 2020-006435 Application 15/352,183 8 Obviousness Rejection of Claims 13–41 The Examiner rejects claims 13–41 under 35 U.S.C. § 103 as being unpatentable over the combination of Goedeken, Lee, and Bonjean. Final Act. 7. The Examiner finds Bonjean teaches rolling out or compressing dough before freezing to reduce the thickness of the dough which in turn optimizes the storage of the dough pieces. Id. The Examiner determines it would have been obvious to one skilled in the art to compress the dough comprising free and encapsulated yeast as taught by the combination of Goedeken and Lee to reduce the volume of the fermented dough pieces to save storage space as taught by Bonjean. Id. According to Appellant, neither Goedeken nor Lee teaches a preserved yeast in any form in a proofed product because Lee’s encapsulated yeast is added to form a product that has not been proofed and that activates during proofing upon exposure to water. Appeal Br. 14. Appellant argues Bonjean does not cure the deficiencies of Goedeken and Lee because it does not disclose a preserved yeast and Bonjean’s dough product is fully proofed before freezing. Id. at 15. Appellant also contends that Bonjean teaches the compressing step has no effect on the final product volume. Id. (citing Bonjean ¶¶ 86, 97). We find Appellant’s arguments persuasive of reversible error. As discussed in connection with claim 1, the Examiner’s finding that Lee’s “protected yeast is capable of surviving the proofing process” is not supported by the record. As Appellant argues, the Examiner’s reliance on Bonjean does not cure the deficiencies of the combination of Goedeken and Lee. Therefore, the preponderance of the evidence in this appeal record does Appeal 2020-006435 Application 15/352,183 9 not support the rejection of claim 13. Accordingly, we reverse the Examiner’s rejection of claim 13, as well as claims 14–41, under 35 U.S.C. § 103 for the same reasons. CONCLUSION For the above reasons, we reverse the Examiner’s rejections of claims 1–12 under 35 U.S.C. § 112(b) for indefiniteness and claims 1–41 under 35 U.S.C. § 103 over the cited prior art references. DECISION SUMMARY In summary: Claims Rejected 35 U.S.C. § Reference(s)/Basis Affirmed Reversed 1–12 112(b) Indefiniteness 1–12 1–12 103 Goedeken, Lee 1–12 13–41 103 Goedeken, Lee, Bonjean 13–41 Overall Outcome 1–41 REVERSED Copy with citationCopy as parenthetical citation